You have 9 free searches left this month | for more free features.

Condition

Glioblastoma Multiforme (2)

Glioblastoma (1)

Glioblastoma Multiforme, Adult (1)

Newly Diagnosed Glioblastoma (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Karyopharm Therapeutics Inc (1)

MimiVax, LLC (1)

Nader Sanai (1)

Collaborator

Barrow Neurological Institute (1)

BeiGene (1)

Imaging Endpoints (1)

Ivy Brain Tumor Center (1)

Translational Drug Development (1)

Study Documents

Intervention Type

drug (2)

radiation (2)

biological (1)

device (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

nGBM

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting

Glioblastoma Multiforme

Selinexor
+6 more

Birmingham, Alabama
+17 more

Apr 1, 2022

Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult Trial in Phoenix (Pamiparib, Olaparib, Radiation therapy)

Recruiting

Glioblastoma
+2 more

Pamiparib
+3 more

Phoenix, Arizona

St. Joseph's Hospital and Medical Center

May 3, 2022

Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)

Recruiting

Newly Diagnosed Glioblastoma

SurVaxM

San Francisco, California
+9 more

Aug 23, 2022